BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04837716-completion@plaintrial.com
DTSTAMP:20261027T062609Z
DTSTART;VALUE=DATE:20270923
SUMMARY:Ensartinib\, Carboplatin\, Pemetrexed and Bevacizumab for the Treat
 ment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Can
 cer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04837716
URL:https://plaintrial.com/trial/NCT04837716
END:VEVENT
END:VCALENDAR